Aggressive infantile myofibromatosis with intestinal involvement

ConclusionsPDGFRB-driven IM is clinically challenging due to its fluctuating course and multiple organ involvement in the first years of life. Early molecular genetic analysis is necessary to consider tyrosine kinase inhibitor treatment in case of aggressive visceral lesions.
Source: Molecular and Cellular Pediatrics - Category: Cytology Source Type: research